시장보고서

상품코드

1515375

세계의 RNA 편집 기술 시장 : RNA 유형별, 기술별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

RNA Editing Technologies Market, By Type of RNA, By Technique, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 375 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

RNA 편집 기술 시장 규모는 2023년에 2억 6,543만 달러로 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 6.8%로 확대

RNA 편집 기술 시장 - 시장 역학

RNA 치료제의 임상 파이프라인 확대가 시장 수요를 촉진

RNA 치료제 분야는 RNA 편집 기술의 진보에 견인되어 최근 몇 년간 상당한 성장을 이루고 있습니다. mRNA 백신, RNA 간섭(RNAi) 치료제, RNA 편집 치료제를 포함한 RNA 기반 치료제는 암과 유전성 질환에서 감염과 신경 질환에 이르기까지 광범위한 질병 치료에 큰 잠재력을 보입니다. RNA 편집 기술은 질병을 일으키는 돌연변이를 수정하고 유전자 발현을 조절하기 위해 RNA 서열에 정확한 수정을 추가 할 수 있으며 RNA 치료제 개발에 매우 중요합니다. 입니다. mRNA 백신의 성공과 RNA 생물학에 대한 이해가 높아짐에 따라 RNA 치료제의 임상 파이프라인이 확대됨에 따라 RNA 편집 기술에 대한 수요가 높아질 것으로 예상됩니다. CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats) 기술은 RNA 편집에 패러다임 이동을 가져오고 RNA 서열을 정확하게 변경하는 능력을 크게 향상 시켰습니다. RNA 편집 분야의 진보에 따라 현재 CRISPR 기반 RNA 편집 플랫폼의 개선과 강화에 초점을 맞춘 연구가 계속되고 있습니다. RNA 분자의 세포 내에서 효율적이고 정확한 타겟팅을 보장하기 위해 전달 메커니즘을 최적화하는 것이 목표입니다. 연구자들은 또한 CRISPR 기반 RNA 편집의 타겟팅 능력과 범용성을 강화함으로써 그 범위를 확대하기 위해 노력하고 있습니다. 이러한 개발은 특히 유전성 질환과 감염에 대한 미래의 치료적 개입에 큰 기대를 갖게 합니다. CRISPR 기반 RNA 편집 기술의 정확성과 적응성 향상은 새로운 치료 전략으로 이어지고 지금까지 치료할 수 없었던 상태의 환자에게 희망을 가져올 것으로 기대됩니다.

RNA 편집 기술 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 6.8%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

RNA 유형별 부문에서 메신저 RNA(mRNA) 변형은 2023년에 최대 시장 점유율을 나타낼 것으로 예측됩니다.

용도별로는 2023년에 암이 주요 유형이었습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

RNA 편집 기술 시장 - 세분화 분석 :

세계의 RNA 편집 기술 시장은 RNA의 유형, 기술, 용도, 지역에 따라 구분됩니다.

시장은 RNA의 유형에 따라 세 가지 범주로 나뉩니다. 메신저 RNA 변형, 트랜스퍼 RNA 변형, 리보솜 RNA 변형입니다. 현재 RNA 편집 기술 시장에서는 메신저 RNA(mRNA) 변형이 주요 부문이 되고 있습니다. mRNA는 유전 정보를 DNA에서 리보솜으로 전달하여 단백질로 번역함으로써 유전자 발현에 필수적입니다. 메틸화 및 아데노신 탈아미노화와 같은 RNA로의 변형은 mRNA의 안정성, 스플라이싱, 국소화, 번역 효율을 조절하여 세포 과정 및 유전자 발현 역학에 영향을 미칩니다.

시장은 용도에 따라 세 가지 범주로 나뉩니다. 암, 유전자 질환, 일시적인 질병입니다. 용도별로 암은 세계 RNA 편집 기술 시장의 주요 부문입니다. 암의 광범위하고 복잡한 성질은 발암의 분자 기전을 이해하고 혁신적인 치료 전략을 개발하기 위한 광범위한 조사 노력을 촉진하고 있습니다. RNA 편집 기술은 종양의 성장, 전이, 치료 저항성과 관련된 비정상적인 RNA 분자를 표적으로 함으로써 암 치료에서 정밀의료에 유망한 기회를 제공합니다.

RNA 편집 기술 시장 - 지리적 통찰

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 있습니다. 이 지역의 고객 국가는 시장을 더욱 세분화합니다. 북미는 세계 RNA 편집 기술 시장의 주요 지역입니다. 이러한 이점은 RNA 편집 기술의 최전선에 있는 유명한 학술 기관, 생명 공학 기지, 제약 회사가 지원하는 견고한 R&D 인프라 등 여러 요인 때문입니다. 기타 특전으로 북미는 정부기관, 민간재단, 벤처캐피탈 기업으로부터 자금을 받고 의료 및 생명공학 연구에 많은 투자를 하고 있습니다. 이러한 투자는 신규 RNA 편집 기술의 개발, 연구의 임상 응용에의 전개, RNA 편집에 근거한 치료법 및 진단법의 상업화를 촉진합니다.

RNA 편집 기술 시장 - 경쟁 구도 :

RNA 편집 기술 경쟁 구도에서 기업은 경쟁력과 시장 우위를 유지하기 위한 전략적 수단을 개발하고 있습니다. 끊임없는 기술 혁신은 CRISPR 기반 시스템과 기본 편집 기술을 포함한 새로운 편집 도구의 개발을 추진하여 RNA 변형의 정확성과 효율성을 향상시킵니다. 학술기관과 생명공학기업과의 공동연구는 최첨단 연구에 대한 접근을 용이하게 하고 기술력을 확대합니다. 규제 준수를 중시함으로써 품질 기준 준수를 보장하고 이해관계자 및 규제기관의 신뢰를 조성합니다. 견고한 지적 재산 포트폴리오는 독자적인 기술을 보호하고 경쟁력을 제공합니다. 또한, 시장에 적극적으로 참여하고 고객에 맞는 지원 서비스가 고객 만족도를 높이고 RNA 편집 솔루션 시장 리더십을 강화하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석-RNA 편집 기술 업계

경쟁 대시보드
기업 프로파일
- ProQR Therapeutics NV
- Sirna Therapeutics, Inc.
- Shape Therapeutics, Inc.
- Korro Bio, Inc.
- Beam Therapeutics, Inc.
- QIAGEN NV
- UniQure NV(UniQure)
- LAVA Therapeutics NV
- argenx SE
- Arrowhead Pharmaceuticals, Inc.
- Others

제12장 애널리스트의 전방위 전망

JHS 24.07.26

REPORT HIGHLIGHT

RNA Editing Technologies Market size was valued at USD 265.43 Million in 2023, expanding at a CAGR of 6.8% from 2024 to 2032.

The field of Global RNA Editing includes a wide range of innovative tools and techniques specifically developed to modify RNA molecules for therapeutic, research, and diagnostic purposes. These RNA editing technologies facilitate targeted changes to RNA sequences, providing unique opportunities to correct genetic mutations, regulate gene expression, and create new RNA-based therapies.

RNA Editing Technologies Market- Market Dynamics

Expanding clinical pipeline of RNA therapeutics to propel market demand

The field of RNA therapeutics has experienced substantial growth in recent years, driven by advancements in RNA editing technologies. RNA-based therapeutics, including mRNA vaccines, RNA interference (RNAi) therapeutics, and RNA editing therapies, show great potential for the treatment of a wide range of diseases, from cancer and genetic disorders to infectious diseases and neurological conditions. RNA editing technologies are crucial in developing RNA therapeutics by enabling precise modifications to RNA sequences to correct disease-causing mutations or modulate gene expression. As the clinical pipeline of RNA therapeutics expands, fueled by the success of mRNA vaccines and the increasing understanding of RNA biology, the demand for RNA editing technologies is expected to rise. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has brought about a paradigm shift in RNA editing, significantly enhancing our ability to precisely modify RNA sequences. As the RNA editing field advances, ongoing research is focused on refining and enhancing CRISPR-based RNA editing platforms. Efforts are aimed at optimizing delivery mechanisms to ensure efficient and accurate targeting of RNA molecules within cells. Researchers are also working to expand the scope of CRISPR-based RNA editing by enhancing its targeting capabilities and versatility. These developments hold significant promise for future therapeutic interventions, especially for genetic disorders and infectious diseases. The increased precision and adaptability of CRISPR-based RNA editing technologies are expected to lead to novel therapeutic strategies, offering hope for patients with previously untreatable conditions.

RNA Editing Technologies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.8% over the forecast period (2024-2032)

Based on Type of RNA segmentation, Messenger RNA (mRNA) modification was predicted to show maximum market share in the year 2023

Based on Application segmentation, cancer was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

RNA Editing Technologies Market- Segmentation Analysis:

The Global RNA Editing Technologies Market is segmented based on Type of RNA, Technique, Application, and Region.

The market is divided into three categories based on Type of RNA: Messenger RNA Modification, Transfer RNA Modification and Ribosomal RNA Modification. Currently, Messenger RNA (mRNA) modification is the leading segment in the RNA Editing Technologies Market. mRNA is essential for gene expression by transferring genetic information from DNA to ribosomes, where it is translated into proteins. Modifications to RNA, such as methylation and adenosine deamination, regulate mRNA stability, splicing, localization, and translation efficiency, thereby influencing cellular processes and gene expression dynamics.

The market is divided into three categories based on Application: Cancer, Genetic Disorders and Temporary Maladies. In terms of application, cancer is the predominant segment in the Global RNA Editing Technologies Market. The widespread and intricate nature of cancer has driven extensive research efforts to understand the molecular mechanisms of oncogenesis and develop innovative therapeutic strategies. RNA editing technologies present promising opportunities for precision medicine in cancer treatment by targeting abnormal RNA molecules associated with tumor growth, metastasis, and therapy resistance.

RNA Editing Technologies Market- Geographical Insights

In terms of geography, this market spans North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Customer nations within these regions further segment the market. North America is the leading region in the Global RNA Editing Technologies Market. This dominance is due to several factors, including a robust research and development infrastructure supported by renowned academic institutions, biotechnology hubs, and pharmaceutical companies that are at the forefront of RNA editing technologies. Additionally, North America benefits from substantial investments in healthcare and biotechnology research, funded by government agencies, private foundations, and venture capital firms. These investments drive the development of novel RNA editing technologies, the translation of research into clinical applications, and the commercialization of RNA editing-based therapies and diagnostics.

RNA Editing Technologies Market- Competitive Landscape:

In the landscape of RNA Editing Technologies, companies deploy strategic measures to maintain competitiveness and market dominance. Continuous innovation drives the development of novel editing tools, including CRISPR-based systems and base editing technologies, enhancing precision and efficiency in RNA modification. Collaborations with academic institutions and biotech firms facilitate access to cutting-edge research and expand technological capabilities. Emphasis on regulatory compliance ensures adherence to quality standards, fostering trust among stakeholders and regulatory bodies. Robust intellectual property portfolios safeguard proprietary technologies, providing a competitive edge. Furthermore, proactive market outreach and tailored customer support services bolster client satisfaction, reinforcing market leadership in RNA editing solutions.

Recent Developments:

In September 2023, Wave Life Sciences applied for a clinical trial of its RNA editing candidate, WVE-006. Upon approval, dosing for the trial began in the U.K. This milestone represents the first instance of an RNA editing candidate advancing to clinical trials, marking a significant achievement in the field.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA EDITING TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

ProQR Therapeutics NV

Sirna Therapeutics, Inc.

Shape Therapeutics, Inc.

Korro Bio, Inc.

Beam Therapeutics, Inc.

QIAGEN N.V.

UniQure NV (UniQure)

LAVA Therapeutics N.V.

argenx SE

Arrowhead Pharmaceuticals, Inc.

Others

GLOBAL RNA EDITING TECHNOLOGIES MARKET, BY TYPE OF RNA - MARKET ANALYSIS, 2019 - 2032

Messenger RNA Modification
Transfer RNA Modification
Ribosomal RNA Modification

GLOBAL RNA EDITING TECHNOLOGIES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

Insertion/ Deletion
Deamination

GLOBAL RNA EDITING TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Genetic Disorders
Temporary Maladies

GLOBAL RNA EDITING TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. RNA Editing Technologies Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. RNA Editing Technologies Market Snippet by Type of RNA
- 2.1.2. RNA Editing Technologies Market Snippet by Technique
- 2.1.3. RNA Editing Technologies Market Snippet by Application
- 2.1.4. RNA Editing Technologies Market Snippet by Country
- 2.1.5. RNA Editing Technologies Market Snippet by Region
2.2. Competitive Insights

3. RNA Editing Technologies Key Market Trends

3.1. RNA Editing Technologies Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. RNA Editing Technologies Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. RNA Editing Technologies Market Opportunities
3.4. RNA Editing Technologies Market Future Trends

4. RNA Editing Technologies Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. RNA Editing Technologies Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. RNA Editing Technologies Market Landscape

6.1. RNA Editing Technologies Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. RNA Editing Technologies Market - By Type of RNA

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type of RNA, 2023 & 2032 (%)
- 7.1.2. Messenger RNA Modification
- 7.1.3. Transfer RNA Modification
- 7.1.4. Ribosomal RNA Modification

8. RNA Editing Technologies Market - By Technique

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
- 8.1.2. Insertion/ Deletion
- 8.1.3. Deamination

9. RNA Editing Technologies Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Genetic Disorders
- 9.1.4. Temporary Maladies

10. RNA Editing Technologies Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. RNA Editing Technologies Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. RNA Editing Technologies Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. RNA Editing Technologies Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. RNA Editing Technologies Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. RNA Editing Technologies Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of RNA, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RNA Editing Technologies Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. ProQR Therapeutics NV
- 11.2.2. Sirna Therapeutics, Inc.
- 11.2.3. Shape Therapeutics, Inc.
- 11.2.4. Korro Bio, Inc.
- 11.2.5. Beam Therapeutics, Inc.
- 11.2.6. QIAGEN N.V.
- 11.2.7. UniQure NV (UniQure)
- 11.2.8. LAVA Therapeutics N.V.
- 11.2.9. argenx SE
- 11.2.10. Arrowhead Pharmaceuticals, Inc.
- 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us